Read more

January 04, 2020
2 min read
Save

Top prevention news of 2019: Women’s heart health, omega-3 updates and more

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Healio and Cardiology Today have compiled a list of the most-popular news on heart disease prevention published in 2019.

In no particular order, Healio readers were most interested in how evening eating impacts heart health in women, the link between insomnia and CV risk, rising rates of CVD in the United States, new prevention guidelines and more.

 

Evening eating may worsen heart health in women

Women who consumed a higher proportion of their daily calories after 6 p.m. had poorer overall CV health and higher BP, BMI and HbA1c levels, researchers reported at the American Heart Association Scientific Sessions. Read more

 

New trial data show mixed findings for omega-3s

The March 2019 Cardiology Today cover story focuses on the growth in popularity of omega-3 supplementation and recent data on omega-3, in supplement and prescription form. Deepak L. Bhatt, MD, MPH, Christie M. Ballantyne, MD, and others weigh in. Read more

 

AHA: Nearly half of all US adults have CVD

At least 48%, or 121.5 million, of all adults in the United States had some form of CVD from 2013 to 2016, according to the American Heart Association’s new Heart and Stroke Statistics. Read more

 

VIDEO: Sex differences, barriers persist for women with heart disease

In this video exclusive, Martha Gulati, MD, MS, FACC, FAHA, with the University of Arizona College of Medicine – Phoenix, Banner University Medicine Heart Institute and editor in chief of ACC’s CardioSmart, discusses the importance of considering sex-specific risk factors for CVD. Read more

 

Intermittent fasting may benefit in metabolic syndrome

Patients with metabolic syndrome who limited their eating to a 10-hour window in addition to statin and antihypertensive medications had reductions in weight, BP, HbA1c and atherogenic lipids, according to a study published in Cell Metabolism. Read more

 

Omega-3 fatty acids with statin therapy reduce major adverse CV events

Eicosapentaenoic acid, or EPA, combined with statin therapy significantly reduced the incidence of major adverse CV events, according to a meta-analysis published in The American Journal of Cardiology. Read more

 

Statin intolerance can be fought with intermittent dosing

Intermittent statin dosing is a treatment option that may have tremendous potential for addressing patients with statin intolerance who are trying to reduce LDL, according to a speaker at the Cardiometabolic Health Congress. Read more

PAGE BREAK

 

Chili pepper consumption may reduce CVD, all-cause mortality

Regular dietary intake of chili peppers conferred lower risk for all-cause and CVD death in Italian adults, independent of CVD risk factors or adherence to a Mediterranean diet, according to research published in the Journal of the American College of Cardiology. Read more

 

Insomnia increases CVD risk

Symptoms of insomnia, specifically difficulties in falling and staying asleep, early morning awakening and daytime dysfunction, were independent risk factors for the incidence of CVD, especially in young adults or those without hypertension, according to a study published in Neurology. Read more

 

Early menopause raises risk for CVD

In a new study, women with natural and surgical premature menopause before age 40 years had a small but significantly elevated risk for a variety of CVDs. CV risk appears to increase with progressively earlier menopausal age and risks may be higher after surgical premature menopause. Read more

 

New prevention guideline: Collaboration encouraged, aspirin downplayed

The new prevention guideline from the American College of Cardiology and the American Heart Association emphasizes team-based care and shared decision-making and recommends against use of aspirin for primary prevention in most adults. Read more